Comparative Effectiveness of Moderate-Intensity Statin With Ezetimibe Combination Therapy Versus High-Intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

被引：0
|
作者：
Jang, Ji-Yong [1 ]
Kim, Seonji [2 ]
Cho, Jaehyeong [2 ]
You, Seng Chan [2 ]
Kim, Jung-Sun [3 ]
机构：
[1] Natl Hlth Insurance Ilsan Hosp, Goyangsi, South Korea
[2] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea
[3] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med,Dept Internal Med, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 82卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-160
引用
收藏
页码：B62 / B62
页数：1
相关论文
共 50 条
  • [31] Low-Intensity Statin Plus Ezetimibe Versus Moderate-Intensity Statin for Primary Prevention: A Population-Based Retrospective Cohort Study in Asian Population
    Jung, Minji
    Lee, Beom-Jin
    Lee, Sukhyang
    Shin, Jaekyu
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (12) : 1193 - 1203
  • [32] Moderate-intensity versus high-intensity statin therapy in Korean patients with angina undergoing percutaneous coronary intervention with drug-eluting stents: A propensity-score matching analysis
    Park, Mahn-Won
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Roh, Jae-Hyung
    Park, Hyun Woo
    Suh, Jon
    Cho, Young-Rak
    Won, Ki-Bum
    Ann, Soe Hee
    Kim, Shin-Jae
    Kim, Dae-Won
    Her, Sung Ho
    Lee, Sang-Gon
    PLOS ONE, 2018, 13 (12):
  • [33] Comparative Effectiveness and Safety of High-Intensity Statin Monotherapy vs. Combination Therapy with Ezetimibe in Post-ACS Lipid Management in Asian Patients: An Observational Cohort Study in Taiwan
    Shen, Chin-Yao
    Hsieh, Miyuki Hsing-Chun
    Tsai, Daniel Hsiang-Te
    Liao, Tzu-Chi
    Lai, Edward Chia-Cheng
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 218 - 218
  • [34] EZETIMIBE INDUCED SEVERE RHABDOMYOLYSIS AFTER LONGSTANDING HIGH-INTENSITY STATIN THERAPY
    Yukselen, Zeynep
    Mohamed, Ahmed
    Filiberti, Allen W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3308 - 3308
  • [35] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Achim Leo Burger
    Nora Beran
    Edita Pogran
    Christoph C. Kaufmann
    David Zweiker
    Marie Muthspiel
    Benjamin Panzer
    Bernhard Jäger
    Miklos Rohla
    Kurt Huber
    Wiener klinische Wochenschrift, 2023, 135 : 674 - 679
  • [36] Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention
    Burger, Achim Leo
    Beran, Nora
    Pogran, Edita
    Kaufmann, Christoph C.
    Zweiker, David
    Muthspiel, Marie
    Panzer, Benjamin
    Jaeger, Bernhard
    Rohla, Miklos
    Huber, Kurt
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (23-24) : 674 - 679
  • [37] Temporal Trends of High-Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention
    Bin Abdulhak, Aref A.
    Vaughan-Sarrzin, Mary
    Kaboli, Peter
    Horwitz, Phillip A.
    Mosher, Hilary
    Sigurdsson, Gardar
    Walker, Nicholas E.
    Wallace, Robert
    Robinson, Jennifer G.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (05):
  • [38] Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease: A Post Hoc Analysis From the RACING Randomized Clinical Trial (vol 8, pg 853, 2023)
    不详
    JAMA CARDIOLOGY, 2023, 8 (09)
  • [39] Real-World Effectiveness of High- Versus Moderate-Intensity Statin Therapy in Thai Patients With Acute Coronary Syndrome and Who Had Undergone Primary Percutaneous Coronary Intervention
    Kunlamas, Yotsaya
    Areepium, Nutthada
    Ariyachaipanich, Aekarach
    Bunditanukul, Krittin
    JOURNAL OF PHARMACY PRACTICE, 2020, 33 (05) : 640 - 646
  • [40] Combination of moderate-intensity statins and ezetimibe versus high-intensity statins alone for primary prevention of cardiovascular events
    Godoy, L. C.
    Kiflen, M.
    Alonzo, R.
    Chu, A.
    Austin, P. C.
    Fang, J.
    Basque, S.
    Lawler, P. R.
    Nunes, J. T.
    Jackevicius, C. A.
    Ko, D. T.
    Lee, D. S.
    Goodman, S. G.
    Farkouh, M. E.
    Udell, J. A.
    EUROPEAN HEART JOURNAL, 2024, 45
12345